Director, Regulatory Affairs Labeling
Revolution Medicines · Remote (United States)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
This posting is pulled directly from Revolution Medicines's own Greenhouse page and applying happens on their site, not here. Posted 2026-08-26; Skip The Boards re-checks every company's board regularly and removes listings that disappear from the source.